Showing 2381-2390 of 4166 results for "".
- CDC: Cases of Vision Loss and Death Due to Drug-Resistant Bacteria Linked to Artificial Tears Continues to Risehttps://modernod.com/news/cdc-cases-of-vision-loss-and-death-due-to-drug-resistant-bacteria-linked-to-artificial-tears-continues-to-rise/2481488/Federal officials say three people have died as part of a growing number of cases of infections from a rare, extensively drug-resistant strain of Pseudomonas aeruginosa found in some artificial tears. There have also been 8 reports of vision loss and 4 reports of enucleatio
- Over 60 Countries and 150 Eye Health Organizations Call on UN to Create a Special Envoy on Visionhttps://modernod.com/news/over-60-countries-and-150-eye-health-organizations-call-on-un-to-create-a-special-envoy-on-vision/2481372/Sixty three countries have written to UN Secretary-General António Guterres calling on him to create a Secretary-General’s "Special Envoy on Vision," according to a news release from the International Agency for the Prevention of Blindness (IAPB). The Envoy w
- Alcon Champions Access to Eye Care with Opening of Children’s Vision Center in Fort Worth, Texashttps://modernod.com/news/alcon-champions-access-to-eye-care-with-opening-of-childrens-vision-center-in-fort-worth-texas/2481337/Alcon announced the grand opening of the Alcon Children’s Vision Center. Located at 8376 Mojave Trail in Fort Worth, Texas, the center is a first-of-its-kind partnership between the Alcon Foundation and the Fort Worth Independent School District (FWISD). The center offers comprehensive
- Johnson & Johnson Vision Receives Approval in Canada for Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Managementhttps://modernod.com/news/johnson-johnson-vision-receives-approval-in-canada-for-acuvue-abiliti-overnight-therapeutic-lenses-for-myopia-management/2481191/Johnson & Johnson Vision received approval from Health Canada for Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management. These orthokeratology (ortho-k) lenses are worn overnight for the control of myopia and are specifically designed to match a patient’s eye based on i
- Johnson & Johnson Vision Introduces Tecnis Symfony OptiBlue EDOF IOL, the Latest PC-IOL Powered by InteliLight Technologyhttps://modernod.com/news/johnson-johnson-vision-introduces-tecnis-symfony-optiblue-edof-iol-the-latest-pc-iol-powered-by-intelilight-technology/2481128/Johnson & Johnson Vision announced availability of a new presbyopia-correcting IOL (PC-IOL) powered by InteliLight technology, Tecnis Symfony OptiBlue IOL. This extended depth-of-focus (EDOF) lens expands presbyopia correction to more patients and joins Tecnis Synergy IOL, a hi
- Pixium Vision Announces Successful Implantation of First Patient in the Netherlands in Prima System European Pivotal Trial PRIMAverahttps://modernod.com/news/pixium-vision-announces-successful-implantation-of-first-patient-in-the-netherlands-in-prima-system-european-pivotal-trial-primavera/2480993/Pixium Vision announced the successful implantation of the first patient in the Netherlands in the PRIMAvera pivotal trial in atrophic dry age-related macular degeneration (AMD). This follows approval of the PRIMAvera study by the Dutch Ministry of Health, Welfare and Sport and the open
- Bausch + Lomb Announces Efficiency-Enhancing Upgrades for Stellaris Elite Vision Enhancement Systemhttps://modernod.com/news/bausch-lomb-announces-efficiency-enhancing-upgrades-for-stellaris-elite-vision-enhancement-system/2480960/Bausch + Lomb announced the first in a series of upgrades for the Stellaris Elite vision enhancement system designed to enhance efficiency. The upgrades include an increase to the maximum vacuum setting from 600 to 660 mmHg and an enhancement to the removable valve caps in the troc
- Johnson & Johnson Vision Introduces Next-Generation TearScience Activator Clear for Treatment of MGDhttps://modernod.com/news/johnson-johnson-vision-introduces-next-generation-tearscience-activator-clear-for-treatment-of-mgd/2480795/Johnson & Johnson Vision announced the availability of the next-generation TearScience Activator Clear. Building on the legacy of the TearScience LipiFlow Thermal Pulsation System—a fully automated treatment for meibomian gland dysfunction (MGD)—Johnson & Johnson Vis
- J&J Vision Presents Data Validating Improved Surgical Outcomes and Surgeon Satisfaction at ASCRShttps://modernod.com/news/johnson-johnson-vision-presents-data-validating-improved-surgical-outcomes-and-surgeon-satisfaction-across-cataract-and-refractive-portfolio-at-ascrs/2480787/Johnson & Johnson Vision will present and/or support 46 company-sponsored and investigator-led studies evaluating innovations and outcomes across its surgical portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Washington, DC, April 22-26.
- Refractive Surgery Council Reports More Than 200,000 Laser Vision Correction Procedures Performed in Q1 2022https://modernod.com/news/refractive-surgery-council-reports-more-than-200000-laser-vision-correction-procedures-performed-in-q1-2022/2480786/The Refractive Surgery Council (RSC) reported laser vision correction (LVC) procedure volume for Q1 2022 at 200,672, representing a 5.3 percent increase over the previous quarter (Q4 2021). The report combines data for LASIK, SMILE and PRK procedures performed in the U.S. as reported by the indus